Suchergebnisse - (Subject:"pseudovirus")

PubPharm (384)

41

A Pseudovirus-Based Entry Assay to Evaluate Neutralizing Activity against Respiratory Syncytial Virus

enthalten in: Viruses | 2023

von Hu, L. | Jiang, J. | Tang, Y. | +7

42

SARS-CoV-2 Prevalence and Variant Surveillance among Cats in Pittsburgh, Pennsylvania, USA

enthalten in: Viruses | 2023

von Ramasamy, S. | Gontu, A. | Neerukonda, S. | +14

43

Pharmacophore variants of the macrocyclic peptide triazole inactivator of HIV-1 Env

enthalten in: Medicinal chemistry research | 2023

von Gupta, M. | Canziani, G. | Ang, C. | +5

44

Pharmacophore variants of the macrocyclic peptide triazole inactivator of HIV-1 Env

enthalten in: Medicinal chemistry research | 2023

von Gupta, M. | Canziani, G. | Ang, C. | +5

45

Pharmacophore variants of the macrocyclic peptide triazole inactivator of HIV-1 Env

enthalten in: Medicinal chemistry research | 2023

von Gupta, M. | Canziani, G. | Ang, C. | +5

46

Antisera Produced Using an E. coli-Expressed SARS-CoV-2 RBD and Complemented with a Minimal Dose of Mammalian-Cell-Expressed S1 Subunit of the Spike Protein Exhibits Improved Neutralization

enthalten in: International journal of molecular sciences | 2023

von Yoshizue, T. | Brindha, S. | Wongnak, R. | +4

47

Development of a Bioluminescent Imaging Mouse Model for SARS-CoV-2 Infection Based on a Pseudovirus System

enthalten in: Vaccines | 2023

von Wu, X. | Fang, N. | Liang, Z. | +6

48

COVID-19 : S-Peptide RBD 484-508 Induces IFN-γ T-Cell Response in Naïve-to-Infection and Unvaccinated Subjects with Close Contact with SARS-CoV-2-Positive Patients

enthalten in: Viruses | 2023

von Murdocca, M. | Citro, G. | Centanini, E. | +9

49

Rapid determination of SARS-CoV-2 antibody neutralization titer using Bio-Rad Bio-Plex correlates strongly with pseudovirus-determined neutralization titer

enthalten in: Journal of virological methods | 2023

von Heaps, A. | Sobolewski, M. | Jacobs, J. | +4

50

Self-replicating RNA nanoparticle vaccine elicits protective immune responses against SARS-CoV-2

enthalten in: Molecular therapy. Nucleic acids | 2023

von Lin, G. | Yan, H. | Sun, J. | +2